MRMC Cancer Miriam


Diversity of the IRB membership is also important in order to sufficiently evaluate the clinical study in terms of science, law, ethics and community attitudes. Membership cannot consist of entirely men or of women or entirely of members of one profession. In addition, there must be at least two members from non-scientific areas. One of those members must not be associated with the institution. Our McLeod Health board consists of 18 individuals who have supported our dedication to patient research and protection.

Members of the Institutional Review Board

Walter E. Connor, MD (IRB Chairman)
Judy Bibbo, MHA (IRB Vice-Chair)
J. Boone Aiken III, Esquire
Marianne Billeter, PharmD, BCPS
John Bruyere, MBA
Jamie Craig, PharmD
Shari Donley, MBA
Joseph E. Heyward, PhD
Gerard Jebaily, MD
C. Lynne Belissary Maroney, MD
Mary Lou Martin, MSN
Hari Rajagopalan, PhD
Sreenivas Rao, MD
Evelyn Roman
Michael Rose, MD
Jeffrey Rossi, MD
Martha Ruff
Marcia Wilds, MHA
Ruth Wittmann-Price, PhD
Robert Youngblood, MD

IRB Administrative Staff

Natalie S. Bee, BS (IRB Coordinator)
Martha Adams, MSN (Oncology Research Nurse)
Gillian Plasman (Cancer Research Coordinator)



The information on this site is intended to increase your awareness and understanding of specific health issues and
services at McLeod Health. It should not be used for diagnosis or as a substitute for health care by your physician.
To report technical issues, please contact us. Public Access to Information or To Report a Concern.

©2012 McLeod Health. Download Vendor Code of Conduct | HIPAA Notice of Privacy Practices | Patient Bill of Rights
Report a Concern | Visitation | Download McLeod Health Mission & Values